Su-Hua Lee

Su-Hua Lee is a Professor of Law at National Taiwan University (NTU) and an affiliate professor in the School of Pharmacy. She has served as a full-time faculty member at NTU since 2016, following academic positions at National Tsing Hua University and National Taipei University. Her expertise spans intellectual property law with specialized focus on pharmaceutical and biotechnology applications, competition law, and civil law.

Her educational background includes:

• Bachelor of Laws from National Taipei University
• Master of Laws (Magister iuris comparativi, M. iur. Comp.) from Rheinischen Friedrich-Wilhelms-Universität Bonn
• Doctor of Laws (PhD) from National Taiwan University in 2006

Professor Lee's research examines the complex interplay between intellectual property frameworks and specialized industries, particularly pharmaceuticals and biotechnology. She has conducted extensive comparative analysis of German and Taiwanese legal systems, informed by her time as a visiting researcher at the Max Planck Institute for Innovation and Competition in Munich (2005-2007). Her scholarship addresses critical issues including patent linkage systems, infringement damages calculation, trade secret protection, and the application of competition law to digital platforms. She frequently bridges theoretical legal concepts with practical policy implications, making her work highly relevant to legislative and regulatory development.

Analysis of her recent publications (2022-2024) reveals three dominant trends: 1) Examination of IP challenges in digital environments (internet marketing, social media trademarks), 2) Pharmaceutical regulation issues (patent linkage, term extension, public health crises), and 3) Economic dimensions of IP enforcement (damages calculation, multi-sided platform economics). Her work consistently incorporates comparative perspectives, particularly from German legal frameworks, while addressing Taiwan-specific legal and policy contexts.

Professor Lee leads a research team that has been instrumental in drafting Taiwan's drug approval-patent linkage legislation since 2015. She serves on governmental expert committees related to intellectual property and pharmaceutical affairs and participates in regional academic networks focused on Asian intellectual property law development. Her research has been supported by multiple grants from Taiwan's Ministry of Science and Technology, Ministry of Health and Welfare, Intellectual Property Court, and Fair Trade Commission.

Her scholarly contributions span numerous law journals in Taiwan and internationally, with publications covering patent law, trademark enforcement, trade secrets, and the intersection of intellectual property with competition policy. She has also contributed chapters to several edited volumes on intellectual property systems in Asia and comparative approaches to patent enforcement.